Ann De Vos
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
BACE1 and Other Alzheimer's-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer's Disease Patients from Cognitively-Impaired Neurosyphilis Patients.
Journal: Journal of Alzheimer's disease : JAD
Published: August 18, 2020
Plasma β-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 27, 2020
The β-Secretase BACE1 in Alzheimer's Disease.
Journal: Biological psychiatry
Published: August 08, 2019
Association of brain network dynamics with plasma biomarkers in subjective memory complainers.
Journal: Neurobiology of aging
Published: July 24, 2019
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 17, 2019
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: November 16, 2018
Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer's Disease: A Pilot Study.
Journal: Dementia and geriatric cognitive disorders extra
Published: March 01, 2018
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.
Journal: Clinical chemistry
Published: October 24, 2017
Digital ELISA for the quantification of attomolar concentrations of Alzheimer's disease biomarker protein Tau in biological samples.
Journal: Analytica chimica acta
Published: July 13, 2017
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.
Journal: BMC neurology
Published: February 23, 2017
The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 10, 2016
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 29, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026